Stefan R Hansson

No ORCID on file · 5 papers in corpus · active 2011-2026

Study types

  • article 4
  • other 1

Condition tags

  • adenomyosis 4
  • endometriosis 2
  • dysmenorrhea 1
  • dyspareunia 1
other 2026
Machine learning prediction of live birth after IVF using the morphological uterus sonographic assessment group features of adenomyosis
Scientific reports ·doi:10.1038/s41598-025-31013-1

UNLABELLED: Predicting live birth after the first IVF/ICSI treatment is challenging, as many factors may interact to affect IVF/ICSI outcomes. Adenomyosis is one factor that impacts live birth rates. Machine learning algorithms have been sh…

article 2024
Correlation of adenomyosis features to live birth rates after the first IVF/ICSI treatment, when using the revised Morphological Uterus Sonographic Assessment group definitions
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14986

INTRODUCTION: Data regarding the impact of adenomyosis on the outcomes after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment are conflicting. Standardized diagnostic criteria are prerequisites for studying …

article 2024
OC11.04: Direct MUSA features of adenomyosis impact live birth rates after first in vitro fertilization / intracytoplasmic sperm injection treatment
·doi:10.1002/uog.27797

To determine the cumulative live birth rate (CLBR) after the first in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) treatment in women with or without direct features of adenomyosis, using the revised Morphological Ut…

article 2024
OP11.06: The predictive value of MUSA features of adenomyosis on live birth is poor, using a machine learning algorithm
·doi:10.1002/uog.27964

To determine the predictive value of Morphological Uterus Sonographic Assessment (MUSA) group features of adenomyosis on cumulative live birth (CLB) after the first in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) tre…

article 2011
P12. Placental gene expression analysis at the end of the first trimester of pregnancy in patients at high risk of subsequent development of preeclampsia
·doi:10.1016/j.preghy.2011.08.073